Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

8.30
Delayed Data
As of Dec 14
 -0.57 / -6.43%
Today’s Change
7.41
Today|||52-Week Range
16.20
-39.06%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy3/24/2017151,177$12.00$1.8M-31.06%
Slawin Kevin M
Chief Technology Officer
Sale12/15/201630,000$15.45$463.5K-46.90%
Slawin Kevin M
Director
Sale2/07/201730,000$12.54$376.2K-33.97%
Baker Bros Advisors Lp
Buy3/24/201715,489$12.00$185.9K-31.06%
Moseley Kenneth Ray
General Counsel & Senior Vice President
Sale7/13/201713,823$12.26$169.5K-32.30%
Musso Alan A
Chief Financial Officer & Treasurer
Sale12/11/201717,117$9.33$159.7K-9.39%
Spencer David M
Chief Scientific Officer
Sale7/10/201710,000$11.54$115.4K-27.13%
Musso Alan A
Chief Financial Officer & Treasurer
Sale5/25/20176,311$12.24$77.2K-31.91%
Musso Alan A
Chief Financial Officer & Treasurer
Sale11/27/20176,206$9.89$61.4K-14.70%
Moseley Kenneth Ray
General Counsel & Senior Vice President
Buy7/13/201713,823$2.55$35.2K-32.30%
Page of 2